Company profile
Antag Therapeutics
Redefining obesity treatment, empowering patients
- Industry
- Biotechnology
- Employees
- 23
- Headquarters
- Copenhagen, Nørrebro
- Founded
- 2017
- LinkedIn followers
- 4,473
- Office locations
- 1
Antag Therapeutics company summary
Antag Therapeutics is a company in the Biotechnology industry, headquartered in Copenhagen, Nørrebro, founded in 2017. On LinkedIn the company has around 23 employees and 4,473 followers.
What technology does Antag Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Antag Therapeutics
Antag Therapeutics is a biotechnology company pioneering personal and flexible obesity treatment through GIP receptor antagonism. Antag’s lead molecule AT-7687 is specifically designed to target and deactivate the GIP receptor, a genetically-validated pathway that contributes to fat storage, insulin resistance, and metabolic dysfunction – and is mechanistically distinct from GLP-1 therapies. Antag’s GIPR antagonist approach stems from the work of the esteemed research teams of Professors Jens Juul Holst and Mette Rosenkilde, two co-founders of the business. Antag’s vision is that all people living with obesity, diabetes and overweight have a personal treatment option that goes beyond weight loss to improve long-term health, without having to compromise on tolerability.
Where is Antag Therapeutics located?
Antag Therapeutics lists 1 location.
Compare companies similar to Antag Therapeutics
More companies in Biotechnology.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Antag Therapeutics antagtx.com | Biotechnology | 23 | 2017 | Copenhagen, Nørrebro |
 Regeneron regeneron.com | Biotechnology | 17,234 | - | Tarrytown, New York |
 Bharat Biotech bharatbiotech.com | Biotechnology | 2,035 | 1996 | Hyderabad, Telangana |
 Enzene Biosciences Ltd enzene.com | Biotechnology | 1,023 | 2008 | Pune, Maharashtra |
| Biotechnology | 393 | - | Bethesda, MD | |
 LifeCell International Pvt.Ltd lifecell.in | Biotechnology | 2,650 | 2004 | Chennai, India |
 TMG - Tropical Melhoramento & Genética tmg.agr.br | Biotechnology | 692 | 2001 | Cambé, PR |
 Organica Biotech organicabiotech.com | Biotechnology | 146 | 2000 | Mumbai, Maharashtra |
 Allogene Therapeutics allogene.com | Biotechnology | 217 | 2017 | South San Francisco, California |
 Labtest Diagnóstica S.A. labtest.com.br | Biotechnology | 227 | 1971 | Lagoa Santa, Minas Gerais |
 Orchard Therapeutics - U.S. orchard-tx.com | Biotechnology | 243 | 2015 | London, United Kingdom |
Frequently asked questions about Antag Therapeutics
What does Antag Therapeutics do?
Antag Therapeutics is a biotechnology company pioneering personal and flexible obesity treatment through GIP receptor antagonism. Antag’s lead molecule AT-7687 is specifically designed to target and deactivate the GIP receptor, a genetically-validated pathway that contributes to fat storage, insulin resistance, and metabolic dysfunction – and is mechanistically distinct from GLP-1 therapies. Antag’s GIPR antagonist approach stems from the work of the esteemed research teams of Professors Jens Juul Holst and Mette Rosenkilde, two co-founders of the business. Antag’s vision is that all people living with obesity, diabetes and overweight have a personal treatment option that goes beyond weight loss to improve long-term health, without having to compromise on tolerability.
How many employees does Antag Therapeutics have?
Antag Therapeutics has around 23 employees on LinkedIn.
Where is Antag Therapeutics headquartered?
Antag Therapeutics is headquartered in Copenhagen, Nørrebro.
When was Antag Therapeutics founded?
Antag Therapeutics was founded in 2017.
Build a lead list from companies like Antag Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.